SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
April 5, 2004
(Date of earliest event reported)
ABIOMED, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-20584 |
|
04-2743260 |
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
|
|
|
|
|
|
|
22 Cherry Hill Drive, Danvers, Massachusetts |
|
01923 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
(978) 777-5410
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Item 5. Other Events.
On April 6, 2004, ABIOMED, Inc. announced the appointment of Michael R. Minogue as its new president and chief executive officer. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
ABIOMED, Inc. |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Charles B. Haaser |
|
|
|
|
Charles B. Haaser |
|
|
|
|
Controller |
|
|
|
|
Principal Accounting Officer |
|
|
|
|
Principal Financial Officer |
|
|
|
|
||
|
|
|
||
|
Date: April 7, 2004 |
|
||
3
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press release dated April 6, 2004 |
4